Regeneron Pharmaceuticals
REGN
#230
Rank
S$122.86 B
Marketcap
S$1,188
Share price
-0.19%
Change (1 day)
23.27%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): S$60.33

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$60.60. In 2025 the company made an earnings per share (EPS) of S$55.62 an increase over its 2024 EPS that were of S$52.74.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$60.338.47%
2025S$55.625.48%
2024S$52.7410.34%
2023S$47.79-8.56%
2022S$52.27-47%
2021S$98.62133.36%
2020S$42.2669.13%
2019S$24.99-14.44%
2018S$29.21100.71%
2017S$14.5531.78%
2016S$11.0438.96%
2015S$7.9572.55%
2014S$4.61-17.55%
2013S$5.59-44.98%
2012S$10.15
2010S-$1.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$22.42-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$3.04-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.55-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA